Market Fit Target large pharma, government R&D, and academic consortia with Obatala Sciences' specialization in obesity, diabetes, energy metabolism, and adipose biology to meet demand for human-relevant preclinical models. ObaCell fat tissue models enable disease modeling and drug screening, and the company provides omics and adipokine data with the option to form white or brown fat to match study design.

Unique Advantage ObaCell Obesity-on-a-Chip offers a differentiator for metabolic disease research by delivering a holistic human adipose tissue model that can simulate fasting and feeding states. Offer integrated readouts beyond traditional assays, including proteomics, genomics, functionality data, and adipokine secretion to support mechanism studies and candidate prioritization.

Strategic Partners Pursue collaborations with CROs, biotech startups, pharma R&D groups, and academic labs needing turnkey adipose tissue models or hydrogel and stem cell products. Leverage recent awards and government recognition to strengthen competitive bids for public contracts and minority-owned supplier programs.

Growth Channels Leverage the small team size as an agile advantage while targeting enterprise pharma and academic centers with direct outreach and inbound marketing using HubSpot, LinkedIn, and other tech assets. Expand procurement channels through platforms like Amazon Business to streamline lab purchasing and reach more research teams.

Data Capabilities Monetize data offerings in proteomics, genomics, functional assays, and adipokine profiling by offering tiered data packages tailored to preclinical programs and biomarker development. Pair data services with ObaCell services for end-to-end solutions, and outline a staged growth plan supported by current funding and awards to scale capabilities and reach.